SYROS PHARMACEUTICALS, INC. Operating Lease Liability
SYROS PHARMACEUTICALS, INC. had Operating Lease Liability of $20.30 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2024-05-14
- 2024-03-31: Operating Lease, Liability $20.30M.
- 2023-12-31: Operating Lease, Liability $20.85M.
- 2023-09-30: Operating Lease, Liability $21.39M.
- 2023-06-30: Operating Lease, Liability $21.89M.
| Period end | Operating Lease, Liability |
|---|---|
| 2024-03-31 | $20.30M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $20.85M 10-K · filed 2024-03-27 |
| 2023-09-30 | $21.39M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $21.89M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $22.38M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $22.86M 10-K · filed 2023-03-02 |
| 2022-09-30 | $23.32M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $23.75M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $24.17M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $24.58M 10-K · filed 2022-03-15 |
| 2021-09-30 | $24.97M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $25.34M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $25.69M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $26.04M 10-K · filed 2021-03-04 |
| 2020-09-30 | $26.37M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $26.68M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $25.53M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $25.05M 10-K · filed 2020-03-05 |
| 2019-09-30 | $20.40M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $17.88M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $1.96M 10-Q · filed 2019-05-01 |